The latest news about the CMCiB. For more news of research at the IGTP, please see our main website.
News
HDAC11 deficiency improves muscle function and regeneration during ageing
Researchers from GRENBA-IGTP have identified the HDAC11 protein, an enzyme involved in cellular regulation, as a new therapeutic target to combat sarcopenia, the loss of muscle mass associated with ageing. The study shows that HDAC11 deficiency reduces muscle atrophy, preserves the muscle stem cell reservoir, promotes regeneration after injury and improves muscle function, opening the door to new strategies to support healthy ageing.
A new mouse model allows for more accurate study of COVID-19 in humans
The study presents a new mouse model that more realistically mimics the disease caused by SARS-CoV-2 in humans, an essential tool for better understanding COVID.
CMCiB hosts the 4th ISMISS/MIS & Endoscopic Spine Forum
The CMCiB facilities have been chosen to host a hands-on cadaver surgery workshop as part of the 4th ISMISS/MIS & Endoscopic Spine Forum.
A study reveals sex differences in experimental liver cirrhosis
Researchers at IGTP have led a study that evaluates, for the first time, the difference between sexes in advanced liver disease in a rat model. The study has been published in the journal Laboratory Animals and has been conducted at the facilities of the CMCiB.
The European project SMA-TB concludes with significant advances in tuberculosis treatment
The SMA-TB project, an initiative coordinated by the Experimental Tuberculosis Unit (UTE) at IGTP and funded by the European Commission's H2020 programme, has reached its conclusion after five years of research aimed at improving tuberculosis treatments.
The second edition of the GrowInn incubator kicks off
The innovation units and researchers of the Innomed program gathered at IGTP to launch the second edition of the GrowInn project incubator. The meeting provided an opportunity to share experiences from the first edition and define the new challenges and objectives for this year.